https://stock.noler.com/us/stock/thoratec-corp https://stock.noler.com/us/stock/thoratec-corp/accounts-payable https://stock.noler.com/us/stock/thoratec-corp/accounts-receivable https://stock.noler.com/us/stock/thoratec-corp/accumulated-depreciation https://stock.noler.com/us/stock/thoratec-corp/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-asset https://stock.noler.com/us/stock/thoratec-corp/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/thoratec-corp/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability-1 https://stock.noler.com/us/stock/thoratec-corp/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/thoratec-corp/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/thoratec-corp/acquisitions https://stock.noler.com/us/stock/thoratec-corp/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/thoratec-corp/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/thoratec-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/thoratec-corp/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities-other https://stock.noler.com/us/stock/thoratec-corp/advertising-expense https://stock.noler.com/us/stock/thoratec-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/thoratec-corp/allocated-share-based-compensation-expense-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/allowance-for-doubtful-accounts-receivable-change https://stock.noler.com/us/stock/thoratec-corp/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/thoratec-corp/amended-reports-10-k https://stock.noler.com/us/stock/thoratec-corp/amended-reports-10-k405 https://stock.noler.com/us/stock/thoratec-corp/amended-reports-10-q https://stock.noler.com/us/stock/thoratec-corp/amortization https://stock.noler.com/us/stock/thoratec-corp/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/thoratec-corp/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/thoratec-corp/aoci https://stock.noler.com/us/stock/thoratec-corp/asset-impairment-charges https://stock.noler.com/us/stock/thoratec-corp/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/thoratec-corp/available-for-sale-current https://stock.noler.com/us/stock/thoratec-corp/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/thoratec-corp/available-for-sale-debt-current https://stock.noler.com/us/stock/thoratec-corp/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/thoratec-corp/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/thoratec-corp/available-for-sale-debt-securities https://stock.noler.com/us/stock/thoratec-corp/available-for-sale-noncurrent https://stock.noler.com/us/stock/thoratec-corp/basic-shares https://stock.noler.com/us/stock/thoratec-corp/business-acquisition-contingent-consideration-at-fair-value-current https://stock.noler.com/us/stock/thoratec-corp/business-acquisition-contingent-consideration-at-fair-value-noncurrent https://stock.noler.com/us/stock/thoratec-corp/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/thoratec-corp/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/thoratec-corp/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/thoratec-corp/buyback-authorization-remaining https://stock.noler.com/us/stock/thoratec-corp/buybacks-form-sc-to-i https://stock.noler.com/us/stock/thoratec-corp/buybacks-share-repurchases https://stock.noler.com/us/stock/thoratec-corp/buybacks-shares-repurchased https://stock.noler.com/us/stock/thoratec-corp/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/thoratec-corp/capital-expenditures https://stock.noler.com/us/stock/thoratec-corp/cash-and-equivalents https://stock.noler.com/us/stock/thoratec-corp/cash-flow-breakdown https://stock.noler.com/us/stock/thoratec-corp/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/thoratec-corp/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/thoratec-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/thoratec-corp/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/thoratec-corp/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/thoratec-corp/clinical-trials https://stock.noler.com/us/stock/thoratec-corp/commitments-and-contingencies https://stock.noler.com/us/stock/thoratec-corp/common-stock-no-par-value https://stock.noler.com/us/stock/thoratec-corp/common-stock-value https://stock.noler.com/us/stock/thoratec-corp/comprehensive-income https://stock.noler.com/us/stock/thoratec-corp/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/thoratec-corp/convertible-long-term-notes-payable https://stock.noler.com/us/stock/thoratec-corp/convertible-notes-payable-current https://stock.noler.com/us/stock/thoratec-corp/cost-of-goods-sold https://stock.noler.com/us/stock/thoratec-corp/cost-of-revenue https://stock.noler.com/us/stock/thoratec-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/thoratec-corp/current-assets https://stock.noler.com/us/stock/thoratec-corp/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/current-income-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/current-liabilities https://stock.noler.com/us/stock/thoratec-corp/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/thoratec-corp/deferred-compensation-plan-assets https://stock.noler.com/us/stock/thoratec-corp/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/deferred-revenue https://stock.noler.com/us/stock/thoratec-corp/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-inventory https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-net-current https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-liabilities https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-liabilities-deferred-expense-capitalized-interest https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-liabilities-gross-current https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-liabilities-other https://stock.noler.com/us/stock/thoratec-corp/deferred-tax-liabilities-undistributed-foreign-earnings https://stock.noler.com/us/stock/thoratec-corp/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/thoratec-corp/depreciation https://stock.noler.com/us/stock/thoratec-corp/depreciation-and-amortization-expense https://stock.noler.com/us/stock/thoratec-corp/diluted-shares https://stock.noler.com/us/stock/thoratec-corp/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/thoratec-corp/discontinued-operation-tax-effect-of-discontinued-operation https://stock.noler.com/us/stock/thoratec-corp/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/thoratec-corp/effective-tax-rate https://stock.noler.com/us/stock/thoratec-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/thoratec-corp/eps https://stock.noler.com/us/stock/thoratec-corp/eps-basic https://stock.noler.com/us/stock/thoratec-corp/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/thoratec-corp/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/thoratec-corp/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/thoratec-corp/financing-cash-flow https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-future-amortization-expense https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/thoratec-corp/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/thoratec-corp/foreign-currency-non-hedging-derivatives-asset-at-fair-value https://stock.noler.com/us/stock/thoratec-corp/foreign-currency-non-hedging-derivatives-liability-at-fair-value https://stock.noler.com/us/stock/thoratec-corp/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/thoratec-corp/foreign-earnings https://stock.noler.com/us/stock/thoratec-corp/foreign-pretax-income https://stock.noler.com/us/stock/thoratec-corp/future-amortization-expense-after-year-five https://stock.noler.com/us/stock/thoratec-corp/future-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/thoratec-corp/future-amortization-expense-year-five https://stock.noler.com/us/stock/thoratec-corp/future-amortization-expense-year-four https://stock.noler.com/us/stock/thoratec-corp/future-amortization-expense-year-one https://stock.noler.com/us/stock/thoratec-corp/future-amortization-expense-year-three https://stock.noler.com/us/stock/thoratec-corp/future-amortization-expense-year-two https://stock.noler.com/us/stock/thoratec-corp/gain-loss-on-foreign-currency-non-hedging-derivatives https://stock.noler.com/us/stock/thoratec-corp/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/thoratec-corp/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/thoratec-corp/goodwill https://stock.noler.com/us/stock/thoratec-corp/goodwill-acquired https://stock.noler.com/us/stock/thoratec-corp/goodwill-impairment-loss https://stock.noler.com/us/stock/thoratec-corp/goodwill-translation-adjustments https://stock.noler.com/us/stock/thoratec-corp/gross-profit https://stock.noler.com/us/stock/thoratec-corp/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/thoratec-corp/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/thoratec-corp/impairment-of-investments https://stock.noler.com/us/stock/thoratec-corp/income-loss-from https://stock.noler.com/us/stock/thoratec-corp/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/income-loss-from-discontinued-operations-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/thoratec-corp/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/thoratec-corp/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/thoratec-corp/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/thoratec-corp/income-loss-from-per-basic-share https://stock.noler.com/us/stock/thoratec-corp/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/thoratec-corp/income-tax https://stock.noler.com/us/stock/thoratec-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/thoratec-corp/income-taxes-paid https://stock.noler.com/us/stock/thoratec-corp/income-taxes-receivable https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/thoratec-corp/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/thoratec-corp/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/thoratec-corp/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/thoratec-corp/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/thoratec-corp/indefinite-lived-intangible-assets-translation-adjustments https://stock.noler.com/us/stock/thoratec-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/thoratec-corp/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/thoratec-corp/interest-and-other-income https://stock.noler.com/us/stock/thoratec-corp/interest-expense https://stock.noler.com/us/stock/thoratec-corp/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/interest-paid https://stock.noler.com/us/stock/thoratec-corp/inventory https://stock.noler.com/us/stock/thoratec-corp/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/thoratec-corp/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/thoratec-corp/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/thoratec-corp/investing-cash-flow https://stock.noler.com/us/stock/thoratec-corp/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/thoratec-corp/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/thoratec-corp/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/thoratec-corp/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/thoratec-corp/liability-for-uncertain-tax-positions-noncurrent https://stock.noler.com/us/stock/thoratec-corp/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/thoratec-corp/net-cash-from https://stock.noler.com/us/stock/thoratec-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/thoratec-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/thoratec-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/thoratec-corp/net-change-in-cash https://stock.noler.com/us/stock/thoratec-corp/net-income https://stock.noler.com/us/stock/thoratec-corp/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/thoratec-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/thoratec-corp/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/thoratec-corp/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/thoratec-corp/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/thoratec-corp/noncash-or-part-noncash-acquisition-intangible-assets-acquired-1 https://stock.noler.com/us/stock/thoratec-corp/noncash-or-part-noncash-acquisition-inventory-acquired https://stock.noler.com/us/stock/thoratec-corp/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/thoratec-corp/noncash-or-part-noncash-acquisition-value-of-liabilities-assumed https://stock.noler.com/us/stock/thoratec-corp/number-of-businesses-acquired https://stock.noler.com/us/stock/thoratec-corp/number-of-defendants https://stock.noler.com/us/stock/thoratec-corp/number-of-operating-segments https://stock.noler.com/us/stock/thoratec-corp/oci-available-for-sale-adjustment-before-reclassification-adjustments-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/oci-available-for-sale-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/thoratec-corp/oci-before-reclassifications-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/thoratec-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/thoratec-corp/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/oci-foreign-currency-translation-gain-loss-arising-tax https://stock.noler.com/us/stock/thoratec-corp/oci-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/oci-net-of-tax-2 https://stock.noler.com/us/stock/thoratec-corp/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/thoratec-corp/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/thoratec-corp/operating-cash-flow https://stock.noler.com/us/stock/thoratec-corp/operating-expenses https://stock.noler.com/us/stock/thoratec-corp/operating-income https://stock.noler.com/us/stock/thoratec-corp/operating-lease-payments-due https://stock.noler.com/us/stock/thoratec-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/thoratec-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/thoratec-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/thoratec-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/thoratec-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/thoratec-corp/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/thoratec-corp/operating-leases-rent-expense-net https://stock.noler.com/us/stock/thoratec-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/thoratec-corp/other-income https://stock.noler.com/us/stock/thoratec-corp/other-noncurrent-assets https://stock.noler.com/us/stock/thoratec-corp/other-noncurrent-liabilities https://stock.noler.com/us/stock/thoratec-corp/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/thoratec-corp/paid-in-capital-equity-component-of-convertible-debt-subsequent-adjustments https://stock.noler.com/us/stock/thoratec-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/thoratec-corp/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/thoratec-corp/patents-active https://stock.noler.com/us/stock/thoratec-corp/patents-pending https://stock.noler.com/us/stock/thoratec-corp/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/thoratec-corp/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/thoratec-corp/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/thoratec-corp/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/thoratec-corp/payments-to-acquire-loans-receivable https://stock.noler.com/us/stock/thoratec-corp/payments-to-acquire-notes-receivable https://stock.noler.com/us/stock/thoratec-corp/preferred-shares-facts https://stock.noler.com/us/stock/thoratec-corp/preferred-stock-no-par-value https://stock.noler.com/us/stock/thoratec-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/thoratec-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/thoratec-corp/prepaid-taxes https://stock.noler.com/us/stock/thoratec-corp/pretax-income-domestic https://stock.noler.com/us/stock/thoratec-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-collection-of-loans-receivable https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-divestiture-of-interest-in-consolidated-subsidiaries https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/thoratec-corp/proceeds-from-stock-plans https://stock.noler.com/us/stock/thoratec-corp/product-warranty-accrual-classified-current https://stock.noler.com/us/stock/thoratec-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/thoratec-corp/property-plant-and-equipment-useful-life-maximum https://stock.noler.com/us/stock/thoratec-corp/property-plant-and-equipment-useful-life-minimum https://stock.noler.com/us/stock/thoratec-corp/property-plant-equipment https://stock.noler.com/us/stock/thoratec-corp/provision-for-doubtful-accounts https://stock.noler.com/us/stock/thoratec-corp/public-float https://stock.noler.com/us/stock/thoratec-corp/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/thoratec-corp/repayments-of-convertible-debt https://stock.noler.com/us/stock/thoratec-corp/research-and-development https://stock.noler.com/us/stock/thoratec-corp/retained-earnings https://stock.noler.com/us/stock/thoratec-corp/revenue https://stock.noler.com/us/stock/thoratec-corp/sec-comment-letters-corresp https://stock.noler.com/us/stock/thoratec-corp/sec-comment-letters-upload https://stock.noler.com/us/stock/thoratec-corp/sec-filings-10-c https://stock.noler.com/us/stock/thoratec-corp/sec-filings-10-k https://stock.noler.com/us/stock/thoratec-corp/sec-filings-10-k405 https://stock.noler.com/us/stock/thoratec-corp/sec-filings-10-q https://stock.noler.com/us/stock/thoratec-corp/sec-filings-15-12g https://stock.noler.com/us/stock/thoratec-corp/sec-filings-25-nse https://stock.noler.com/us/stock/thoratec-corp/sec-filings-425 https://stock.noler.com/us/stock/thoratec-corp/sec-filings-8-a12g https://stock.noler.com/us/stock/thoratec-corp/sec-filings-8-k https://stock.noler.com/us/stock/thoratec-corp/sec-filings-ars https://stock.noler.com/us/stock/thoratec-corp/sec-filings-def-14a https://stock.noler.com/us/stock/thoratec-corp/sec-filings-defa14a https://stock.noler.com/us/stock/thoratec-corp/sec-filings-defm14a https://stock.noler.com/us/stock/thoratec-corp/sec-filings-no-act https://stock.noler.com/us/stock/thoratec-corp/sec-filings-pre-14a https://stock.noler.com/us/stock/thoratec-corp/sec-filings-prem14a https://stock.noler.com/us/stock/thoratec-corp/sec-filings-s-4 https://stock.noler.com/us/stock/thoratec-corp/sec-filings-sd https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-effect https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-rw https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/thoratec-corp/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/thoratec-corp/sga-expense https://stock.noler.com/us/stock/thoratec-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/thoratec-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/thoratec-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/thoratec-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/thoratec-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-remaining-term https://stock.noler.com/us/stock/thoratec-corp/shareholders-equity https://stock.noler.com/us/stock/thoratec-corp/shares-authorized https://stock.noler.com/us/stock/thoratec-corp/shares-issued https://stock.noler.com/us/stock/thoratec-corp/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/thoratec-corp/significant-change-in-utb-is-reasonably-possible-estimated-range-of-change-upper-bound https://stock.noler.com/us/stock/thoratec-corp/significant-purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/thoratec-corp/standard-product-warranty-accrual https://stock.noler.com/us/stock/thoratec-corp/standard-product-warranty-accrual-change https://stock.noler.com/us/stock/thoratec-corp/standard-product-warranty-accrual-payments https://stock.noler.com/us/stock/thoratec-corp/standard-product-warranty-accrual-warranties-issued https://stock.noler.com/us/stock/thoratec-corp/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/thoratec-corp/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/thoratec-corp/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/thoratec-corp/stock-award-rsu-outstanding-remaining-term https://stock.noler.com/us/stock/thoratec-corp/stock-based-compensation https://stock.noler.com/us/stock/thoratec-corp/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/thoratec-corp/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/thoratec-corp/stock-compensation-tax-benefit-realized-from-exercise-of-stock-options https://stock.noler.com/us/stock/thoratec-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/thoratec-corp/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/thoratec-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/thoratec-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/thoratec-corp/stock-repurchase-program-authorized-amount https://stock.noler.com/us/stock/thoratec-corp/stock-repurchase-program-remaining-authorized-repurchase-amount https://stock.noler.com/us/stock/thoratec-corp/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/thoratec-corp/tangible-asset-impairment-charges https://stock.noler.com/us/stock/thoratec-corp/tax-benefit-from-stock-options-exercised https://stock.noler.com/us/stock/thoratec-corp/tax-benefit-from-stock-options-exercised-1 https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/thoratec-corp/tax-rate-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/thoratec-corp/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/thoratec-corp/total-assets https://stock.noler.com/us/stock/thoratec-corp/total-liabilities https://stock.noler.com/us/stock/thoratec-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/thoratec-corp/undistributed-earnings-allocated-to-participating-securities https://stock.noler.com/us/stock/thoratec-corp/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/thoratec-corp/unrecognized-tax-benefits https://stock.noler.com/us/stock/thoratec-corp/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/thoratec-corp/utb-decrease-from-settlements https://stock.noler.com/us/stock/thoratec-corp/utb-income-tax-penalties-accrued https://stock.noler.com/us/stock/thoratec-corp/utb-income-tax-penalties-expense https://stock.noler.com/us/stock/thoratec-corp/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/thoratec-corp/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/thoratec-corp/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/thoratec-corp/utb-interest-on-income-taxes-expense https://stock.noler.com/us/stock/thoratec-corp/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/thoratec-corp/utb-that-would-impact-effective-tax-rate